UK Markets closed

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
132.80+12.60 (+10.48%)
At close: 4:25PM CEST
Full screen
Previous close120.20
Open122.40
Bid131.80 x N/A
Ask139.00 x N/A
Day's range122.00 - 135.00
52-week range46.00 - 141.00
Volume143,782
Avg. volume65,041
Market cap4.25B
Beta (5Y monthly)1.40
PE ratio (TTM)N/A
EPS (TTM)-3.96
Earnings date11 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Ultimovacs ASA: Second Quarter 2021 Result Presentation

    OSLO, Norway, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces its second quarter 2021 results today. A presentation by the Company's management team will take place today on a webcast at 09:00 CEST. The presentation can be followed as a live webcast (access through the link https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210820_5 ) which will also be available on our website. Highl

  • Globe Newswire

    Ultimovacs Announces Further Positive Topline Results from Phase I UV1 Cancer Vaccine Combination Study in Metastatic Melanoma

    Cohort 2 showed 60% objective response rate, 30% complete response rate90% overall survival rate at 12 months follow-upCohort 2 results reinforce results seen in cohort 1Good safety and tolerability profile supports use of UV1 in combination treatments OSLO, Norway, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced positive topline results from the second cohort of 10 patients after one year of

  • Globe Newswire

    Ultimovacs ASA: Invitation to Second Quarter 2021 Results Webcast Presentation

    OSLO, Norway, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, invites to a webcast presentation of its second quarter 2021 results on Friday 20 August 2021. The presentation can be followed as a live webcast (access through link https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210820_5) at 09:00 CET on Friday 20 August 2021. The webcast presentation will be available on the Ultimovacs website